ONCO - Onconetix, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.7 -0.17 (-4.59%)	---	---	---	-0.18 (-4.86%)	-0.1 (-2.83%)	-0.03 (-0.84%)	-0.03 (-0.84%)

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -4.76
Diluted EPS:: -4.76
Basic P/E:: -0.7416
Diluted P/E:: -0.7416
RSI(14) 1m:: 100.0
VWAP:: 3.53
RVol:: 0.057

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	3.64 +0.08 (+2.25%)	Oct 15 13:02
1m	Price increase 1m	3.65 +0.11 (+3.11%)	Oct 15 09:57
10m	Price increase 10m	3.65 +0.11 (+3.11%)	Oct 15 09:57
60m	Price decrease 60m	3.51 -0.2 (-5.34%)	Oct 15 09:45
10m	Price decrease 10m	3.21 -0.49 (-13.24%)	Oct 15 04:24